Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars.
These recommendations on how to care for babies who fail newborn screenings offer valuable lessons for public health officials, clinicians, and families.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
The preliminary results from three clinical trials administering gene therapy to address deafness from otoferlin mutations mark inspiring and incredible progress in hearing healthcare.
Eli Lilly said its experimental gene therapy restored hearing in a boy born with profound hearing loss. The results for this experimental treatment come three months after Regeneron Pharmaceuticals reported early but encouraging data for its hearing loss gene therapy.
A hearing healthcare veteran consultant, who has significant hearing loss, describes 7 market-tested best practices. Understanding the consumer-patient journey is crucial to developing strategic priorities for companies across hearing healthcare, from hearing aids to cochlear implants to gene/drug therapy.
Some patients recognize no words at all 12 months after surgery, while others essentially have normal hearing in our analysis. This wide range of speech perception outcomes, we conclude, translates into considerable uncertainty for patients.
How to turn analytics into actual policy outcomes.
Strategies for combating the infiltration of a set of societal beliefs that leads to poor health outcomes is what makes anti-smoking campaigns a compelling analog on the eve of a new OTC hearing aid category.
An overlooked yet central aspect of Apple’s solution is that the AirPods Pro now integrates customized amplification with hearing protection against noise in a single device.
A bill introduced by Sens. Elizabeth Warren (D-Massachusetts) and Rand Paul (R-Kentucky) in March would allow patients to visit an audiologist to get a hearing test to diagnose a hearing problem without first being referred by a physician or nurse practitioner.
Oticon, the company behind the Opn hearing aid, also has a hearing aid app called HearingFitness. It functions somewhat like a fitness tracker and gives users advice and encouragement about their hearing well-being.
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Now that President Trump has signed the Over-The-Counter Hearing Aid Act into law, hearing companies are advancing towards the starting blocks for what's shaping up to be a new race to solve hearing loss.
Two of the hottest fields in biopharma got another boost this week, with a $32 million Series A raised by a regenerative medicine startup and a separate $40 million in financing for the treatment of liver fibrosis and NASH.
Their efforts will most likely not reach the clinic before late 2018, but the two companies have a lot of motivation.
Decibel Therapeutics, a Third Rock-backed startup, was just launched in Boston to treat a wide range of hearing loss disorders. It just closed out a $52 million Series A.
Hearing loss may be more than frustrating millions of older adults, but it may also signal a greater risk of death, according to the results of a new study. Adults ages 70 years or older with moderate or more severe hearing impairment have a 54% increased risk of all causes of death, as compared to […]